Profiling the expression of fatty acid-binding proteins and fatty acid transporters in mouse microglia and assessing their role in docosahexaenoic acid-d5 uptake

Pioglitazone Increases Blood–Brain Barrier Expression of Fatty Acid-Binding Protein 5 and Docosahexaenoic Acid Trafficking into the Brain

(2020) Yi Ling Low et al.   MOLECULAR PHARMACEUTICS

Glucose transporter 1 critically controls microglial activation through facilitating glycolysis

(2019) Luxi Wang et al.   Molecular Neurodegeneration

Carboxylated Cy5-Labeled Comb Polymers Passively Diffuse the Cell Membrane and Target Mitochondria

(2019) Ayaat M. Mahmoud et al.   ACS Applied Materials & Interfaces

Fatty Acid–Binding Protein 5 Mediates the Uptake of Fatty Acids, but not Drugs, Into Human Brain Endothelial Cells

(2018) Gordon S. Lee et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets

(2017) Yijun Pan et al.   JOURNAL OF NEUROCHEMISTRY

The blood-brain barrier and protein-mediated fatty acid uptake: role of the blood-brain barrier as a metabolic barrier

(2017) Eric J. Murphy   JOURNAL OF NEUROCHEMISTRY

Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation

(2017) Cayla M. Duffy et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Fatty acid transporting proteins: Roles in brain development, aging, and stroke

(2017) Wenting Zhang et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Fatty Acid-Binding Protein 5 at the Blood–Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function

(2016) Yijun Pan et al.   JOURNAL OF NEUROSCIENCE

The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation

(2016) Anja Henn   ALTEX-Alternatives to Animal Experimentation

Fatty Acid-Binding Protein 5 Facilitates the Blood–Brain Barrier Transport of Docosahexaenoic Acid

(2015) Yijun Pan et al.   MOLECULAR PHARMACEUTICS

Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

(2014) Long N. Nguyen et al.   NATURE

Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study

(2013) Y. Freund Levi et al.   JOURNAL OF INTERNAL MEDICINE

SLC27 fatty acid transport proteins

(2013) Courtney M. Anderson et al.   MOLECULAR ASPECTS OF MEDICINE

FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation

(2011) Kazem Sharifi et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Genetic Ablation of CD36 Does not Alter Mouse Brain Polyunsaturated Fatty Acid Concentrations

(2010) Byung Jun Song et al.   LIPIDS

Effect of dietary docosahexaenoic acid on biosynthesis of docosahexaenoic acid from alpha-linolenic acid in young rats

(2008) James C. DeMar et al.   JOURNAL OF LIPID RESEARCH

Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization

(2008) Véronique De Smedt-Peyrusse et al.   JOURNAL OF NEUROCHEMISTRY

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets

(2008) Masato Furuhashi et al.   NATURE REVIEWS DRUG DISCOVERY

DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice

(2008) C.R. Hooijmans et al.   NEUROBIOLOGY OF DISEASE